In fact, pharmacological modulation and remodeling of adipose tissues ameliorated systemic insulin resistance and enhanced insulin-dependent glucose uptake by suppressing fat depot-related ATM in obesity [13, 14]. The gene discussed is INS; the disease is obesity disorder.